Provided by Tiger Trade Technology Pte. Ltd.

Alvotech

4.43
+0.16003.75%
Post-market: 4.540.1054+2.38%19:45 EDT
Volume:2.27M
Turnover:10.15M
Market Cap:1.50B
PE:-16.04
High:4.60
Open:4.32
Low:4.32
Close:4.27
52wk High:9.25
52wk Low:2.94
Shares:338.22M
Float Shares:122.00M
Volume Ratio:2.99
T/O Rate:1.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2762
EPS(LYR):0.0964
ROE:--
ROA:2.19%
PB:-7.82
PE(LYR):45.97

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood, Mobileye

Reuters
·
Jun 16

BUZZ-Alvotech slides on $152 mln share sale

Reuters
·
Jun 16

Press Release: Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement

Dow Jones
·
Jun 16

Alvotech prices unregistered sale of 17,826,666 shares at $3.75 each

Reuters
·
Jun 16

BRIEF-Alvotech Prices Offering Of 22.67 Million Ordinary Shares At $3.75 Per Share

Reuters
·
Jun 16

Alvotech prices 22,666,667-share offering at $3.75 per share

Reuters
·
Jun 16

Alvotech - Prices Offering of 22.67 Mln Ordinary Shares at $3.75 per Share

THOMSON REUTERS
·
Jun 16

Alvotech TBA Spot Secondary; price range $3.75-$undefined

TIPRANKS
·
Jun 16

Alvotech Launches Public Offering, Private Placement of Ordinary Shares

MT Newswires Live
·
Jun 16

Alvotech Halts Use of ATM Prospectus Supplement While Keeping Jefferies Sales Agreement Intact

TIPRANKS
·
Jun 16

Alvotech launches USD 125 million public share offering, concurrent private placement

Reuters
·
Jun 16

Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares

THOMSON REUTERS
·
Jun 16

Alvotech Sa: to Use Net Proceeds From Offering & Concurrent Private Placement to Fund Continued Development of Its Biosimilar Assets

THOMSON REUTERS
·
Jun 16

Why Alvotech (ALVO) Is Up 17.8% After FDA Advances Its Entyvio Biosimilar AVT16 Application

Simply Wall St.
·
Jun 14

Alvotech Wins FDA Review for Entyvio Biosimilar AVT16 as Q1 2026 Results Filed

TIPRANKS
·
Jun 09

Alvotech Says FDA Agreed to Review Application for Biosimilar of Entyvio; Shares Rise Pre-Bell

MT Newswires Live
·
Jun 08

Reg-Alvotech Announces FDA Acceptance of Biologics License Application for Avt16, a Proposed Interchangeable Biosimilar to Entyvio®

THOMSON REUTERS
·
Jun 08

Alvotech says FDA accepts AVT16 biosimilar application for review

Reuters
·
Jun 08

Alvotech Resubmits US Market Applications for Johnson & Johnson and Regeneron Biosimilars

Deep News
·
Jun 05

Nordic Stocks Gain; Alvotech Leads Increases

Dow Jones
·
Jun 05